Global Insulin Glargine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Insulin Glargine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Insulin Glargine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Insulin Glargine by Country/Region, 2017, 2022 & 2028

2.2 Insulin Glargine Segment by Type

2.2.1 Single Dose Vial

2.2.2 Pre-filled Syringe

2.3 Insulin Glargine Sales by Type

2.3.1 Global Insulin Glargine Sales Market Share by Type (2017-2022)

2.3.2 Global Insulin Glargine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Insulin Glargine Sale Price by Type (2017-2022)

2.4 Insulin Glargine Segment by Application

2.4.1 Treat Type2 Diabetes

2.4.2 Treat Type1 Diabetes

2.5 Insulin Glargine Sales by Application

2.5.1 Global Insulin Glargine Sale Market Share by Application (2017-2022)

2.5.2 Global Insulin Glargine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Insulin Glargine Sale Price by Application (2017-2022)

3 Global Insulin Glargine by Company

3.1 Global Insulin Glargine Breakdown Data by Company

3.1.1 Global Insulin Glargine Annual Sales by Company (2020-2022)

3.1.2 Global Insulin Glargine Sales Market Share by Company (2020-2022)

3.2 Global Insulin Glargine Annual Revenue by Company (2020-2022)

3.2.1 Global Insulin Glargine Revenue by Company (2020-2022)

3.2.2 Global Insulin Glargine Revenue Market Share by Company (2020-2022)

3.3 Global Insulin Glargine Sale Price by Company

3.4 Key Manufacturers Insulin Glargine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Insulin Glargine Product Location Distribution

3.4.2 Players Insulin Glargine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Insulin Glargine by Geographic Region

4.1 World Historic Insulin Glargine Market Size by Geographic Region (2017-2022)

4.1.1 Global Insulin Glargine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Insulin Glargine Annual Revenue by Geographic Region

4.2 World Historic Insulin Glargine Market Size by Country/Region (2017-2022)

4.2.1 Global Insulin Glargine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Insulin Glargine Annual Revenue by Country/Region

4.3 Americas Insulin Glargine Sales Growth

4.4 APAC Insulin Glargine Sales Growth

4.5 Europe Insulin Glargine Sales Growth

4.6 Middle East & Africa Insulin Glargine Sales Growth

5 Americas

5.1 Americas Insulin Glargine Sales by Country

5.1.1 Americas Insulin Glargine Sales by Country (2017-2022)

5.1.2 Americas Insulin Glargine Revenue by Country (2017-2022)

5.2 Americas Insulin Glargine Sales by Type

5.3 Americas Insulin Glargine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Insulin Glargine Sales by Region

6.1.1 APAC Insulin Glargine Sales by Region (2017-2022)

6.1.2 APAC Insulin Glargine Revenue by Region (2017-2022)

6.2 APAC Insulin Glargine Sales by Type

6.3 APAC Insulin Glargine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Insulin Glargine by Country

7.1.1 Europe Insulin Glargine Sales by Country (2017-2022)

7.1.2 Europe Insulin Glargine Revenue by Country (2017-2022)

7.2 Europe Insulin Glargine Sales by Type

7.3 Europe Insulin Glargine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Insulin Glargine by Country

8.1.1 Middle East & Africa Insulin Glargine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Insulin Glargine Revenue by Country (2017-2022)

8.2 Middle East & Africa Insulin Glargine Sales by Type

8.3 Middle East & Africa Insulin Glargine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Insulin Glargine

10.3 Manufacturing Process Analysis of Insulin Glargine

10.4 Industry Chain Structure of Insulin Glargine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Insulin Glargine Distributors

11.3 Insulin Glargine Customer

12 World Forecast Review for Insulin Glargine by Geographic Region

12.1 Global Insulin Glargine Market Size Forecast by Region

12.1.1 Global Insulin Glargine Forecast by Region (2023-2028)

12.1.2 Global Insulin Glargine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Insulin Glargine Forecast by Type

12.7 Global Insulin Glargine Forecast by Application

13 Key Players Analysis

13.1 Sanofi-Aventis

13.1.1 Sanofi-Aventis Company Information

13.1.2 Sanofi-Aventis Insulin Glargine Product Offered

13.1.3 Sanofi-Aventis Insulin Glargine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sanofi-Aventis Main Business Overview

13.1.5 Sanofi-Aventis Latest Developments

13.2 Ganlee

13.2.1 Ganlee Company Information

13.2.2 Ganlee Insulin Glargine Product Offered

13.2.3 Ganlee Insulin Glargine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Ganlee Main Business Overview

13.2.5 Ganlee Latest Developments

13.3 Biocon

13.3.1 Biocon Company Information

13.3.2 Biocon Insulin Glargine Product Offered

13.3.3 Biocon Insulin Glargine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Biocon Main Business Overview

13.3.5 Biocon Latest Developments

14 Research Findings and Conclusion

Table 1. Insulin Glargine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Insulin Glargine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Single Dose Vial

Table 4. Major Players of Pre-filled Syringe

Table 5. Global Insulin Glargine Sales by Type (2017-2022) & (M mL)

Table 6. Global Insulin Glargine Sales Market Share by Type (2017-2022)

Table 7. Global Insulin Glargine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Insulin Glargine Revenue Market Share by Type (2017-2022)

Table 9. Global Insulin Glargine Sale Price by Type (2017-2022) & (USD/mL)

Table 10. Global Insulin Glargine Sales by Application (2017-2022) & (M mL)

Table 11. Global Insulin Glargine Sales Market Share by Application (2017-2022)

Table 12. Global Insulin Glargine Revenue by Application (2017-2022)

Table 13. Global Insulin Glargine Revenue Market Share by Application (2017-2022)

Table 14. Global Insulin Glargine Sale Price by Application (2017-2022) & (USD/mL)

Table 15. Global Insulin Glargine Sales by Company (2020-2022) & (M mL)

Table 16. Global Insulin Glargine Sales Market Share by Company (2020-2022)

Table 17. Global Insulin Glargine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Insulin Glargine Revenue Market Share by Company (2020-2022)

Table 19. Global Insulin Glargine Sale Price by Company (2020-2022) & (USD/mL)

Table 20. Key Manufacturers Insulin Glargine Producing Area Distribution and Sales Area

Table 21. Players Insulin Glargine Products Offered

Table 22. Insulin Glargine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Insulin Glargine Sales by Geographic Region (2017-2022) & (M mL)

Table 26. Global Insulin Glargine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Insulin Glargine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Insulin Glargine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Insulin Glargine Sales by Country/Region (2017-2022) & (M mL)

Table 30. Global Insulin Glargine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Insulin Glargine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Insulin Glargine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Insulin Glargine Sales by Country (2017-2022) & (M mL)

Table 34. Americas Insulin Glargine Sales Market Share by Country (2017-2022)

Table 35. Americas Insulin Glargine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Insulin Glargine Revenue Market Share by Country (2017-2022)

Table 37. Americas Insulin Glargine Sales by Type (2017-2022) & (M mL)

Table 38. Americas Insulin Glargine Sales Market Share by Type (2017-2022)

Table 39. Americas Insulin Glargine Sales by Application (2017-2022) & (M mL)

Table 40. Americas Insulin Glargine Sales Market Share by Application (2017-2022)

Table 41. APAC Insulin Glargine Sales by Region (2017-2022) & (M mL)

Table 42. APAC Insulin Glargine Sales Market Share by Region (2017-2022)

Table 43. APAC Insulin Glargine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Insulin Glargine Revenue Market Share by Region (2017-2022)

Table 45. APAC Insulin Glargine Sales by Type (2017-2022) & (M mL)

Table 46. APAC Insulin Glargine Sales Market Share by Type (2017-2022)

Table 47. APAC Insulin Glargine Sales by Application (2017-2022) & (M mL)

Table 48. APAC Insulin Glargine Sales Market Share by Application (2017-2022)

Table 49. Europe Insulin Glargine Sales by Country (2017-2022) & (M mL)

Table 50. Europe Insulin Glargine Sales Market Share by Country (2017-2022)

Table 51. Europe Insulin Glargine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Insulin Glargine Revenue Market Share by Country (2017-2022)

Table 53. Europe Insulin Glargine Sales by Type (2017-2022) & (M mL)

Table 54. Europe Insulin Glargine Sales Market Share by Type (2017-2022)

Table 55. Europe Insulin Glargine Sales by Application (2017-2022) & (M mL)

Table 56. Europe Insulin Glargine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Insulin Glargine Sales by Country (2017-2022) & (M mL)

Table 58. Middle East & Africa Insulin Glargine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Insulin Glargine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Insulin Glargine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Insulin Glargine Sales by Type (2017-2022) & (M mL)

Table 62. Middle East & Africa Insulin Glargine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Insulin Glargine Sales by Application (2017-2022) & (M mL)

Table 64. Middle East & Africa Insulin Glargine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Insulin Glargine

Table 66. Key Market Challenges & Risks of Insulin Glargine

Table 67. Key Industry Trends of Insulin Glargine

Table 68. Insulin Glargine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Insulin Glargine Distributors List

Table 71. Insulin Glargine Customer List

Table 72. Global Insulin Glargine Sales Forecast by Region (2023-2028) & (M mL)

Table 73. Global Insulin Glargine Sales Market Forecast by Region

Table 74. Global Insulin Glargine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Insulin Glargine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Insulin Glargine Sales Forecast by Country (2023-2028) & (M mL)

Table 77. Americas Insulin Glargine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Insulin Glargine Sales Forecast by Region (2023-2028) & (M mL)

Table 79. APAC Insulin Glargine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Insulin Glargine Sales Forecast by Country (2023-2028) & (M mL)

Table 81. Europe Insulin Glargine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Insulin Glargine Sales Forecast by Country (2023-2028) & (M mL)

Table 83. Middle East & Africa Insulin Glargine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Insulin Glargine Sales Forecast by Type (2023-2028) & (M mL)

Table 85. Global Insulin Glargine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Insulin Glargine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Insulin Glargine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Insulin Glargine Sales Forecast by Application (2023-2028) & (M mL)

Table 89. Global Insulin Glargine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Insulin Glargine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Insulin Glargine Revenue Market Share Forecast by Application (2023-2028)

Table 92. Sanofi-Aventis Basic Information, Insulin Glargine Manufacturing Base, Sales Area and Its Competitors

Table 93. Sanofi-Aventis Insulin Glargine Product Offered

Table 94. Sanofi-Aventis Insulin Glargine Sales (M mL), Revenue ($ Million), Price (USD/mL) and Gross Margin (2020-2022)

Table 95. Sanofi-Aventis Main Business

Table 96. Sanofi-Aventis Latest Developments

Table 97. Ganlee Basic Information, Insulin Glargine Manufacturing Base, Sales Area and Its Competitors

Table 98. Ganlee Insulin Glargine Product Offered

Table 99. Ganlee Insulin Glargine Sales (M mL), Revenue ($ Million), Price (USD/mL) and Gross Margin (2020-2022)

Table 100. Ganlee Main Business

Table 101. Ganlee Latest Developments

Table 102. Biocon Basic Information, Insulin Glargine Manufacturing Base, Sales Area and Its Competitors

Table 103. Biocon Insulin Glargine Product Offered

Table 104. Biocon Insulin Glargine Sales (M mL), Revenue ($ Million), Price (USD/mL) and Gross Margin (2020-2022)

Table 105. Biocon Main Business

Table 106. Biocon Latest Developments

List of Figures

Figure 1. Picture of Insulin Glargine

Figure 2. Insulin Glargine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Insulin Glargine Sales Growth Rate 2017-2028 (M mL)

Figure 7. Global Insulin Glargine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Insulin Glargine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Single Dose Vial

Figure 10. Product Picture of Pre-filled Syringe

Figure 11. Global Insulin Glargine Sales Market Share by Type in 2021

Figure 12. Global Insulin Glargine Revenue Market Share by Type (2017-2022)

Figure 13. Insulin Glargine Consumed in Treat Type2 Diabetes

Figure 14. Global Insulin Glargine Market: Treat Type2 Diabetes (2017-2022) & (M mL)

Figure 15. Insulin Glargine Consumed in Treat Type1 Diabetes

Figure 16. Global Insulin Glargine Market: Treat Type1 Diabetes (2017-2022) & (M mL)

Figure 17. Global Insulin Glargine Sales Market Share by Application (2017-2022)

Figure 18. Global Insulin Glargine Revenue Market Share by Application in 2021

Figure 19. Insulin Glargine Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Insulin Glargine Revenue Market Share by Company in 2021

Figure 21. Global Insulin Glargine Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Insulin Glargine Revenue Market Share by Geographic Region in 2021

Figure 23. Global Insulin Glargine Sales Market Share by Region (2017-2022)

Figure 24. Global Insulin Glargine Revenue Market Share by Country/Region in 2021

Figure 25. Americas Insulin Glargine Sales 2017-2022 (M mL)

Figure 26. Americas Insulin Glargine Revenue 2017-2022 ($ Millions)

Figure 27. APAC Insulin Glargine Sales 2017-2022 (M mL)

Figure 28. APAC Insulin Glargine Revenue 2017-2022 ($ Millions)

Figure 29. Europe Insulin Glargine Sales 2017-2022 (M mL)

Figure 30. Europe Insulin Glargine Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Insulin Glargine Sales 2017-2022 (M mL)

Figure 32. Middle East & Africa Insulin Glargine Revenue 2017-2022 ($ Millions)

Figure 33. Americas Insulin Glargine Sales Market Share by Country in 2021

Figure 34. Americas Insulin Glargine Revenue Market Share by Country in 2021

Figure 35. United States Insulin Glargine Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Insulin Glargine Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Insulin Glargine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Insulin Glargine Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Insulin Glargine Sales Market Share by Region in 2021

Figure 40. APAC Insulin Glargine Revenue Market Share by Regions in 2021

Figure 41. China Insulin Glargine Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Insulin Glargine Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Insulin Glargine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Insulin Glargine Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Insulin Glargine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Insulin Glargine Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Insulin Glargine Sales Market Share by Country in 2021

Figure 48. Europe Insulin Glargine Revenue Market Share by Country in 2021

Figure 49. Germany Insulin Glargine Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Insulin Glargine Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Insulin Glargine Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Insulin Glargine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Insulin Glargine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Insulin Glargine Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Insulin Glargine Revenue Market Share by Country in 2021

Figure 56. Egypt Insulin Glargine Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Insulin Glargine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Insulin Glargine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Insulin Glargine Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Insulin Glargine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Insulin Glargine in 2021

Figure 62. Manufacturing Process Analysis of Insulin Glargine

Figure 63. Industry Chain Structure of Insulin Glargine

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles